Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Authors
Keywords
-
Journal
BMC CANCER
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2011-11-16
DOI
10.1186/1471-2407-11-486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
- (2010) M. E. Straver et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- (2010) Gunter von Minckwitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy
- (2010) Rohit Bhargava et al. CANCER
- Neue Konzepte in der zielgerichteten systemischen Therapie des Mammakarzinoms
- (2010) C. Liedtke et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
- (2010) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
- (2010) Abigail S. Caudle et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
- (2010) Luca Gianni et al. LANCET
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
- (2008) Alfonso Sánchez-Muñoz et al. Clinical & Translational Oncology
- Bootstrap estimated true and false positive rates and ROC curve
- (2008) Werner Adler et al. COMPUTATIONAL STATISTICS & DATA ANALYSIS
- Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer
- (2008) Jennifer K. Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started